Zafgen (ZFGN) Tops Q1 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. NVDA
7. CRBU
8. HALO
9. BBIO
10. SPY

Go back to Zafgen (ZFGN) Tops Q1 EPS by 10c

Zafgen Reports First Quarter 2016 Financial Results

May 10, 2016 4:07 PM EDT

BOSTON, May 10, 2016 (GLOBE NEWSWIRE) -- Zafgen (Nasdaq: ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today announced its first quarter 2016 financial results, and provided an update on the Companys clinical program for beloranib.

The compelling and consistent efficacy data emerging from our beloranib clinical trials in both PWS and severe obesity complicated by type 2 diabetes provide greater perspective on the efficacy-safety profile of beloranib in difficult-to-treat obesity indications, said Thomas Hughes, Ph.D., Chief Executive Officer of... More